Axon Partners Group S.A. (APG) - Total Liabilities
Based on the latest financial reports, Axon Partners Group S.A. (APG) has total liabilities worth €6.70 Million EUR (≈ $7.83 Million USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore APG operating cash flow to assess how effectively this company generates cash.
Axon Partners Group S.A. - Total Liabilities Trend (2019–2024)
This chart illustrates how Axon Partners Group S.A.'s total liabilities have evolved over time, based on quarterly financial data. Check Axon Partners Group S.A. liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Axon Partners Group S.A. Competitors by Total Liabilities
The table below lists competitors of Axon Partners Group S.A. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aerovate Therapeutics Inc
NASDAQ:AVTE
|
USA | $2.49 Million |
|
South West Pinnacle Exploration Limited
NSE:SOUTHWEST
|
India | Rs1.40 Billion |
|
SanDi Properties Co Ltd
TW:1438
|
Taiwan | NT$11.29 Billion |
|
Thinkific Labs Inc
TO:THNC
|
Canada | CA$19.49 Million |
|
Vocento
MC:VOC
|
Spain | €173.46 Million |
|
UY Scuti Acquisition Corp.
NASDAQ:UYSC
|
USA | $58.23 Million |
|
Asetek A/S
F:A31
|
Germany | €35.78 Million |
Liability Composition Analysis (2019–2024)
This chart breaks down Axon Partners Group S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see APG company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Axon Partners Group S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Axon Partners Group S.A. (2019–2024)
The table below shows the annual total liabilities of Axon Partners Group S.A. from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €6.70 Million ≈ $7.83 Million |
-6.65% |
| 2023-12-31 | €7.18 Million ≈ $8.39 Million |
+39.79% |
| 2022-12-31 | €5.14 Million ≈ $6.00 Million |
-31.53% |
| 2021-12-31 | €7.50 Million ≈ $8.77 Million |
+19.49% |
| 2020-12-31 | €6.28 Million ≈ $7.34 Million |
+3.35% |
| 2019-12-31 | €6.07 Million ≈ $7.10 Million |
-- |
About Axon Partners Group S.A.
Axon Partners Group, S.A. is a private equity and venture capital firm specializing in all stages from seed to growth capital, growth equity, startups, lower middle market, early stage, pre-IPO, IPO, post IPO, expansion, mid venture, late venture sustainability, debt instrument, private debt and fund of funds investment. Within fund of funds, the firm seeks to invest in all sectors and stages fro… Read more